№;Year;Report title;Institute

1;1992;Report (interim) «Development of methods of use of waste extract production from velvet antlers and cut horns of reindeer in livestock» Academy of Sciences of Russia;Siberian Department Yakut Institute of Biology 2;1994;Report on the assessment of the biological activity of the drug «P» on the model of the short-term culture of human epidermal cells;NGO «COMETOLOGY» 3;1994;Report on the experimental testing of the drug made of powder of reindeer antlers - drug «P»;NGO «COMETOLOGY» 4;1995;Report on the experimental study of «Cigapan» drug on the model of bone fracture; National Medical Research Center for Traumatology and Orthopedicsnamed after N.N. Priorov 5;1995;Report on the experimental study of the wound-healing action of «Cigapan» drug on the model of gunshot skin-muscle wound;National Medical Research Center for Traumatology and Orthopedics named after N.N. Priorov 6;1995;Report on evaluation of potential cytogenetic activity of «Cigapan» drug;Research Institute of Preventive Toxicology and Disinfection of the Russian Federation 7;1995;Report on pharmacological and toxicological examination of powder from reindeer antlers;State Institute of Blood Substitution and Medicines 8;1995;Report on the study of the «Cigapan» drug for indicators of peripheral blood and bone marrow in rats;Hematology Research Center RAMS 9;1995;Report on the study of «Cigapan» drug on the indicators of peripheral blood of bone marrow;Hematology Research Center RAMS 10;1995;Performance report;Central Research Institute of gastroenterology 11;1996;Report on the study of the toxicomodifying action of new «Cigapan» drug;«TOXOFORM» LLP 12;1996;Report on the study of the toxicomodifying activity of «Cigapan» drug;«TOXOFORM» LLP 13;1996;Report on the test actions of «Cigapan» drug on the organs of the urogenital system;Research Institute of Urology of the Russian Ministry of Health 14;1996;Conclusion on testing «Cigapan» drug with experimental tuberculosis in inbred mice;RAMS Tuberculosis Research Institute 15;1996;Report on the work done. Conclusion on the effectiveness of «Cigapan» drug for experimental stomach ulcer in rats;Central Research Institute of gastroenterology 16;1999;Report on the biological testing of «Cigapan» (from reindeer antlers) on the effect on some indicators of the state of the endocrine system and metabolism;Laboratory of Pathological Physiology of the Institute of Experimental Endocrinology RAMS 17;1999;Report on the experimental study of anabolic properties of «Cigapan»;Institute of Physical Culture and Sports 18;1999;Report on research work «Experimental study of influence of «Cigapan» food supplement on removal of Sr from the organism, as well as availability of osteotropic element of calcium, present in «Cigapan» for assimilation;Federal Office of Medical-Biological and Extreme Problems under the Ministry of Health of the Russian Federation 19;2001;Report on the research work «Preclinical research of the biologically active additive «Cigapan»;Research Institute of Narcology of the Ministry of Health of the Russian Federation 20;2002;Report on the test on dogs of «Cigapan» food supplement when it is used for therapeutic purposes;Research Institute of Urology of the Russian Ministry of Health 21;2002;Report on the test on dogs of «Cigapan» when it is used for prophylactic purposes by the;Research Institute of Urology Research Institute of Urology of the Russian Ministry of Health 22;2002;Act on testing the effectiveness of «Cigapan» for the prevention of sexual dysfunction in dogs; Research Institute of Urology of the Russian Ministry of Health 23;2002;The act on testing the effectiveness of «Cigapan» for the prevention of anaemia in dogs;Research Institute of Urology of the Russian Ministry of Health 24;2002;Act on testing the effectiveness of «Cigapan» for the prevention of kidney failure in dogs; Research Institute of Urology of the Russian Ministry of Health 25;2002;The act on testing the effectiveness of «Cigapan» for the treatment of acute and chronic cystitis in dogs;Research Institute of Urology of the Russian Ministry of Health 26;2002;The act on testing the effectiveness of «Cigapan» for the treatment of chronic kidney failure in dogs;Research Institute of Urology of the Russian Ministry of Health 27;2002;Act on testing the effectiveness of «Cigapan» for the prevention of hypocalcemia in dogs;Research Institute of Urology of the Russian Ministry 28;2002;The act on testing the effectiveness of «Cigapan» to prevent the suppuration of wounds in dogs;Research Institute of Urology of the Russian Ministry of Health 29;2004;Conclusion;Research Instituteof Carcinogenesis named after N.N. Blokhin RAMS 30;2004;Final report Study of acute oral toxicity of powder from reindeer antlers (Cigapan) after a 14-day study in a rat;Pharmaceutical Laboratory of Control and Development Co LTD Budapest 31;2004;Report - I Pharmaceutical; Laboratory of Control and Development Co LTD Budapest

№;Year;Report title;Institute

1;1996;About the results of clinical trials of food supplements «Cigapan» (patients with hypertension disease I-II stage and associated obesity I-II degree);Research Institute of Nutrition RAMS 2;1999;About the clinical-pharmacological research of the «Cigapan» on the physical efficiency of highly qualified athletes;Institute of Physical Culture and Sports 3;1999;About the clinical-pharmacological research into the effectiveness and safety of «Cigapan» in the treatment of sexual dysfunctions in men;Centre for Medical Sexology and Sex Pathology 4;1999;Clinical-pharmacological study of «Cigapan»’s effect on humoral immunity of highly qualified athletes; Institute of Physical Culture and Sports 5;1999;About the results of clinical trials of «Cigapan» (when treating type II diabetes); Research Institute of Nutrition RAMS 6;1999;About the results of clinical trials of «Cigapan» (in patients with chronic diseases of the gastroduodenal zone); Research Institute of Nutrition RAMS 7;2000;Studying the effectiveness of «Cigapan» in persons affected by the accident at the Chernobyl Nuclear Power Plant;Radiological Medical Center RAMS 8;2000;On research of influence of «Cigapan» in patients with platelets;Hematology Research Centre RAMS 9;2000;About the clinical trial of «Cigapan» (in haemophiliacs patients);Hematology Research Centre RAMS 10;2000;About the clinical use of «Cigapan»(prostatitis, gunshot wounds);Main Military Clinical Hospital of the Russian Ministry of Internal Affairs 11;2000;About the study of the influence of «Cigapan» in patients with reduced thyroid function;Research Institute of Neurology RAMS 12;2000;About the study of the influence of «Cigapan» in patients with increased thyroid function;Research Institute of Neurology RAMS 13;2001;About the clinical trial of «Cigapan» (in the treatment of children with various genetically determined pathology accompanied by osteoporosis);Research Institute of Pediatrics and Pediatric Surgery of the Russian Ministry of Health 14;2001;About the results of clinical trials of «Cigapan» (children living in radiologically contaminated territories); Federal Children’s Scientific and Practical Center for Radiation Protection of Pediatrics and Children’s Surgery of the Russian Ministry of Health 15;2001;About the results of clinical trials of «Cigapan» (intestinal dysbacteriosis); Research Institute of Pediatrics and Pediatric Surgery of the Russian Ministry of Health 16;2001;About the results of clinical trials of «Cigapan» (vegetable-vascular dystonia, vasotonic type);Research Institute of Pediatrics and Pediatric Surgery of the Russian Ministry of Health 17;2001;About the clinical trials of «Cigapan» in haematological patients (lymphogranulematosis);Hematology Research 18;2001;Protocol of clinical trials in patients with acute poisoning with psychopharmacological preparations, drugs, carbon monoxide;N. V. Sklyfosovsky Research Institute for Acute Poisoning Treatment 19;2001;Protocol of clinical trials in patients with open injuries and complicated wound process;Scientific Research Institute of Emergency Medicine of N. V. Sklifosovsky 20;2002;About clinical study of «Cigapan» effectiveness and safety in children with nephrotic form of glomerulonephritis who received long-term prednisolone therapy;Research Institute of Pediatrics and Pediatric Surgery of the Russian Ministry of Health 21;2002;About the clinical trial of «Cigapan» (children with different nosological forms of genetically determined diseases accompanied by osteoporosis);Research Institute of Pediatrics and Pediatric Surgery of the Russian Ministry of Health 22;2002;About the clinical research of «Cigapan» at combined chemotherapy of patients with destructive pulmonary tuberculosis;RAMS Tuberculosis Research Institute 23;2002;About the results of application of «Cigapan» (in patients with ischemic heart disease and patients aged 62-70 without clinical manifestations of IHD); Gerontology Research Institute RNI Clinic 24;2002;About clinical studies on the influence of «Cigapan» on the immune system in patients with type I diabetes;Department of Endocrinology and Diabetology of Sechenov Medical Academy 25;2002;Study of influence of «Cigapan» on insulin and blood glucose in healthy people (under load);Scientific Center of Physical Culture and Sports Institute 26;2002;Study of influence of «Cigapan» on insulin and blood glucose content in healthy people (fasting);Scientific Center of Physical Culture and Sports Institute 27;2002;Study of the influence of «Cigapan» on the content of insulin and blood glucose in healthy people (eating);Scientific Center of Physical Culture and Sports Institute 28;2003;About clinical trials of «Cigapan» in children with bronchial asthma;Research Institute of Pediatrics and Pediatric Surgery of the Russian Ministry of Health 29;2003;Review-report on the conducted clinical trial of «Cigapan» (neurological diseases accompanied by degenerative-dystrophic and painful manifestations);Neurological Department of Saint-Petersburg Clinical Hospital RAS 30;2003;On conducting clinical trials of «Cigapan»;Russian Scientific Center of Radiology of Health Ministry 31;2003;Determining the influence of therapeutic doses of Cigapan on the dynamics of beta-endorphins and glucose in the blood of different groups of examined patients;Research Institute of Influenza of Russian Academy of Medical Sciences 32;2003;About the clinical trials of «Cigapan» on the state of the immune system in patients with enterovirus infections; Research Institute of Influenza of Russian Academy of Medical Sciences 33;2003;About clinical trials of «Cigapan» for atopic dermatitis in children;Research Institute of Pediatrics and Pediatric Surgery of the Russian Ministry of Health 34;2004;On conducting clinical trials of «Cigapan» for treatment of patients with hepatitis B and C;Research Institute of Influenza of Russian Academy of Medical Sciences 35;2004;nfluence of Cigapan on the microelement status of children with microelementosis from ecologically disadvantaged region;MUZ Volskaya Children's Hospital 36;2004;Studying the influence of «Cigapan» on microelement status of breastfeeding mothers and babies;MUZ Volskaya Children's Hospital 37;2004;Report on the comparative randomized double-blind placebo-controlled clinical study of the efficacy and safety of powders from ossified reindeer antlers (Cigapan) in the complex therapy of metabolic syndrome; State Department of Preventive Medicine of Russian Ministry of Health